|
|
[交流]
【其他】藥明康德偉業(yè)蓬勃發(fā)展 已有25人參與
按照公司大樓啟用的先后順序編號,位于外高橋保稅區(qū)德林路90號已經(jīng)竣工的兩幢大樓被編為藥明康德12#和13#大樓,
日期已經(jīng)陸續(xù)搬入啟用。以下是12#和13#大樓的現(xiàn)場照片。

藥明康德偉業(yè)蓬勃發(fā)展,讓我們高歌猛進,用智慧和勤勞的雙手,筑起更加雄偉的藥明康德大廈。
Ground Breaking Ceremony of WuXi AppTec Biopharmaceuticals Co., Ltd.
Successfully Held in WuXi
On June 11, The ground breaking ceremony of WuXi AppTec Biophamaceuticals Co., Ltd. was successfully held in the city of WuXi. Mr. Yang Weize, Member of the Standing Committee of Jiangsu Provincial CPC Committee and Secretary of WuXi Municipal CPC Committee, Mr. Mao Xiaoping, Mayor of WuXi, Mr. Gong Peixing, chairman of WuXi City's Political Consultative Conference, and government officials from related departments, together with the delegation led by Dr. Ge Li, chairman of CEO of WuXi AppTec, attended the ceremony.
WuXi AppTec Biopharmaceuticals Co., Ltd., a wholly-owned subsidiary of WuXi AppTec, is a new biotechnology R&D and manufacturing services outsourcing company. With a registered investment of 15 million US dollars and a facility area of 67,000 square meters, the new company aims at building up a world-class biopharmaceutical outsourcing service base with the most advanced technology and compliance with the standards of FDA, to provide monoclonal antibody, vaccine, protein recombinant related “one-stop” R&D services to global biotech companies.
Ni Bin, assistant to WuXi mayor addressed that WuXi and Binhu government will give preferential policy and environmental support to WuXi AppTec to leverage its talents, company brand and international influence in order to build a new company in Binhu. Taking the advantages of the parent company’s cutting-edge technology and research scientists in biologics, the new company will provide global biotech companies with new biotech R&D services and the research and manufacturing services for generic drugs in the biotechnology industry as well.
Zhu Weiping, Secretary of BinHu District CPC Committee said that the establishment of WuXi AppTec Biopharmaceuticals Co., Ltd., will definitely attract a large quantity of elite talents, leading groups and institutions to the city of WuXi, bring investment from key enterprises and promote the development of WuXi biotechnology industry.
Dr. Ge Li expressed his gratitude to the recognition and support from WuXi government. “Over 4200 employees of WuXi AppTec will make more efforts and contributions, to support the development of WuXi Bio-pharmaceutical R&D Outsourcing Service Park”, commented Dr. Li.
無錫藥明康德生物技術(shù)有限公司奠基儀式成功舉行
2010年6月11日,無錫藥明康德生物技術(shù)有限公司奠基儀式在無錫生物醫(yī)藥研發(fā)服務(wù)外包區(qū)成功舉行。省委常委、無錫市委書記楊衛(wèi)澤、無錫市人民政府市長毛小平、無錫市政協(xié)主席貢培興等市區(qū)領(lǐng)導、度假區(qū)領(lǐng)導和藥明康德董事長兼首席執(zhí)行官李革博士帶領(lǐng)的藥明康德代表團成員參加了奠基儀式。
無錫藥明康德生物技術(shù)有限公司是藥明康德新藥開發(fā)有限公司投資建立的生物藥物研發(fā)和生產(chǎn)服務(wù)外包項目,該項目注冊資本1億元,占地100畝,將采用美國公司專有技術(shù)和人才,按照FDA等國際先進標準建設(shè)一流的生物藥物外包服務(wù)基地。建成后能為全球生物制藥公司提供單克隆抗體、疫苗、重組蛋白等生物藥物“一站式”的研發(fā)和生產(chǎn)外包服務(wù)。
無錫市人民政府市長助理倪斌表示,無錫市領(lǐng)導及濱湖區(qū)政府,將在政策扶持和經(jīng)營環(huán)境上積極支持藥明康德發(fā)揮人才、品牌的優(yōu)勢,利用藥明康德的國際影響力,利用藥明康德?lián)碛械纳镱I(lǐng)先技術(shù)和研發(fā)團隊,面向國內(nèi)外生物醫(yī)藥企業(yè)提供新型生物藥研發(fā)服務(wù),并涉足生物仿制藥行業(yè)的研發(fā)和生產(chǎn)服務(wù)。
無錫市濱湖區(qū)區(qū)委書記朱渭平表示,這一舉措,同時也必將吸引一批海內(nèi)外頂尖人才、領(lǐng)軍團隊和機構(gòu)到無錫,吸引關(guān)鍵企業(yè)到無錫投資,推動無錫生物醫(yī)藥產(chǎn)業(yè)的發(fā)展。
李革博士在奠基儀式上,對無錫市各級政府對藥明康德的認可和支持表達了感謝,并表示藥明康德的全體員工將以更大的努力,支持無錫馬山生物醫(yī)藥產(chǎn)業(yè)基地的發(fā)展。

[ Last edited by zlwcw on 2010-6-12 at 15:20 ] |
» 收錄本帖的淘帖專輯推薦
» 猜你喜歡
» 本主題相關(guān)價值貼推薦,對您同樣有幫助:
|